Your browser doesn't support javascript.
loading
Management of Optic Pathway Glioma: A Systematic Review and Meta-Analysis.
Yousefi, Omid; Azami, Pouria; Sabahi, Mohammadmahdi; Dabecco, Rocco; Adada, Badih; Borghei-Razavi, Hamid.
Afiliação
  • Yousefi O; Trauma Research Center, Shiraz University of Medical Sciences, Shiraz 71348, Iran.
  • Azami P; Trauma Research Center, Shiraz University of Medical Sciences, Shiraz 71348, Iran.
  • Sabahi M; Neurosurgery Research Group (NRG), Student Research Committee, Hamadan University of Medical Sciences, Hamadan 65141, Iran.
  • Dabecco R; Department of Neurological Surgery, Pauline Braathen Neurological Center, Cleveland Clinic Florida, Weston, FL 33331, USA.
  • Adada B; Department of Neurological Surgery, Pauline Braathen Neurological Center, Cleveland Clinic Florida, Weston, FL 33331, USA.
  • Borghei-Razavi H; Department of Neurological Surgery, Pauline Braathen Neurological Center, Cleveland Clinic Florida, Weston, FL 33331, USA.
Cancers (Basel) ; 14(19)2022 Sep 30.
Article em En | MEDLINE | ID: mdl-36230704
ABSTRACT

Background:

OPG accounts for 3−5% of childhood central nervous system (CNS) tumors and about 2% of pediatric glial lesions.

Methods:

Article selection was performed by searching PubMed, Web of Science, and Cochrane databases.

Results:

The pooled mortality rate was 0.12 (95%CI 0.09−0.14). Due to the unrepresentative data, improved and not changed outcomes were classified as favorable outcomes and worsened as unfavorable. Meta-analyses were performed to determine the rate of clinical and radiological favorable outcomes. In terms of visual assessment, the pooled rate of a favorable outcome in chemotherapy, radiotherapy, and surgery was 0.74, 0.81, and 0.65, respectively, and the overall pooled rate of the favorable outcome was 0.75 (95%CI 0.70−0.80). In terms of radiological assessment, the rate of a favorable outcome following chemotherapy, radiotherapy, and surgery was 0.71, 0.74, and 0.67, respectively, and the overall pooled rate of the favorable outcome is 0.71 (95%CI 0.65−0.77). The subgroup analysis revealed no significant difference in the rate of clinical and radiological favorable outcomes between the different treatment modalities (p > 0.05).

Conclusion:

Our analyses showed that each therapeutic modality represents viable treatment options to achieve remission for these patients.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article